The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.445
Bid: 0.43
Ask: 0.46
Change: -0.015 (-3.26%)
Spread: 0.03 (6.977%)
Open: 0.46
High: 0.46
Low: 0.445
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post Period End Trading Update

19 Jul 2022 07:00

RNS Number : 8714S
Haydale Graphene Industries PLC
19 July 2022
 

This announcement contains inside information.

 

 

For immediate release

19 July 2022

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

Post period end trading update

Haydale, (AIM: HAYD), the global advanced materials group, announces a trading update for the year ended 30 June 2022 (the "Year" or "FY2022").

The Group now anticipates, subject to audit, announcing revenues for the Year ahead of prior expectations at approximately £2.90 million with gross profit of approximately £1.74 million and LBITDA marginally behind prior guidance at £3.35 million. Capital Expenditure in the Year was £1.00 million and Year end cash stood at £1.19 million.

As previously indicated, the commercial momentum from the second half of the Year is expected to accelerate into the new financial year with both an increased customer and product portfolio contributing to this. Against this increase, the annualised impact of the investment in sales, marketing, quality and production resource during FY2022 alongside the inflationary cost pressures we are seeing at our operating units will partly offset the expected uplift in revenue at the LBITDA level. We anticipate that the current year LBITDA will be smaller than FY2022 but not to the extent previously expected.

Notwithstanding this, with the significant increase that the HT1400 has delivered to the Group's functionalisation capacity combined with the investment made in human capital the Board remains confident that it has the fundamental building blocks in place to take advantage of the commercial traction it is seeing. The Board remain confident in the medium and longer term prospects for the Group.

 

For further information:

 

 

Haydale Graphene Industries plc

Keith Broadbent, CEO

Mark Chapman, CFO

Tel: +44 (0) 1269 842 946

 

www.haydale.com 

finnCap (Nominated Adviser & Broker)

Julian Blunt/Edward Whiley, Corporate FinanceAndrew Burdis, ECM

 

Tel: +44 (0) 20 7220 0500

 

Notes to Editors

 

Haydale is a global technologies group and service provider that facilitates the integration of graphene and other nanomaterials into the next generation of industrial materials and commercial technologies. With expertise in graphene, other nanomaterials and Silicon Carbide, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, Haydale has been granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from five sites in the UK, USA and East Asia. For more information please visit: www.haydale.com or Twitter: @haydalegraphene

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRPMATMTABBJT
Date   Source Headline
26th Oct 20219:05 amRNSSecond Price Monitoring Extn
26th Oct 20219:00 amRNSPrice Monitoring Extension
18th Oct 20217:00 amRNSNotice of Results
20th Sep 202111:49 amRNSResult of Oversubscribed Fundraising
20th Sep 20217:01 amRNSPrimaryBid Offer
20th Sep 20217:00 amRNSProposed Placing and Subscription
1st Sep 20217:00 amRNSUS Small Business Administration Loan Agreement
19th Aug 20217:00 amRNSHigh Performance Garments – Used in Tokyo
16th Aug 20217:51 amRNSFiling of Joint Patent with Airbus
2nd Aug 20217:00 amRNSIssue of Warrants
12th Jul 20217:00 amRNSCollaboration agreement with ProMake Limited
28th May 20212:05 pmRNSSecond Price Monitoring Extn
28th May 20212:01 pmRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSExtension to CeramycGuard Distributor Agreement
6th Apr 20217:00 amRNSFeasibility Study Award
29th Mar 20217:00 amRNS401 Tech Bridge Partners with Haydale
26th Mar 202111:11 amRNS£1.1 million Innovate UK Loan Agreement
25th Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSBiwater Trial CeramycShield™ Treatment
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSInterim Results
9th Feb 20217:00 amRNSFunctionalised Masterbatch Used in Bolflex Sole
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSSales Representation Agreement and Trading Update
18th Jan 20219:00 amRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
8th Dec 202012:09 pmRNSResult of AGM
7th Dec 202012:30 pmRNSDistributor Agreement for iCraft PPE Mask
27th Nov 20207:00 amRNSFunctionalised Graphene Antibacterial Masks
18th Nov 20204:40 pmRNSSecond Price Monitoring Extn
18th Nov 20204:35 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSNotice of Annual General Meeting
30th Oct 20207:00 amRNSFull Year Results
15th Sep 202010:36 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSContracts Signed with Dowty Propellers
9th Sep 202011:06 amRNSSecond Price Monitoring Extn
9th Sep 202011:00 amRNSPrice Monitoring Extension
9th Sep 20209:05 amRNSSecond Price Monitoring Extn
9th Sep 20209:00 amRNSPrice Monitoring Extension
9th Sep 20208:00 amRNSResult of Fundraising
9th Sep 20207:01 amRNSiCraft Order and Global Exclusivity Contract
9th Sep 20207:00 amRNSProposed Placing and Subscription
8th Sep 20204:40 pmRNSSecond Price Monitoring Extn
8th Sep 20204:35 pmRNSPrice Monitoring Extension
7th Sep 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.